You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1626 to 1650 of about 5901
Next 25
09/07/2016
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
The fourth weapon in the battle against cancer
09/01/2016
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.
Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.
08/31/2016
Musella Foundation Copay Assistance Program reopens!
Immunotherapy, Vaccines Offer Promise in Glioblastoma, But Data is Still Preliminary
Kadmon launches mid-stage study of lead oncology candidate in brain cancer
08/25/2016
NY Islanders fundraiser for Brain Tumor Research!
08/24/2016
Update published for "Treatment Options For Glioblastoma and other Glioma"
08/23/2016
Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.
08/18/2016
Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
08/16/2016
Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
08/13/2016
MANY CANCER PATIENTS MUST FACE BANKRUPTCY—OR DIE
08/10/2016
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.
Call for chefs to enter Flo’s Chili Cook-Off
07/26/2016
NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
International Study Finds Effective, Less Toxic Way to Treat Brain Tumors
Musella Foundation awards $149,992 in 3 brain tumor research grants.
Musella Foundation Co-payment Assistance Program is now closed to new patients
07/25/2016
NCCN updated CNS cancer treatment guidelines to include Optune
Musella Foundation Co-payment Assistance Program about to close to new patients